The voluntary action affects devices manufactured before May 12, 2025, after reports of component detachment linked to patient injuries and one death, with Olympus reinforcing safeguards to prioritise patient safety....
The new CLIA-waived immunoassay enables simultaneous detection of influenza A/B and SARS-CoV-2 in just 10 minutes, supporting faster, cost-effective decision-making at the point of care....
The partnership integrates Lunit’s oncology-focused AI with Agilent’s diagnostic expertise to accelerate biomarker testing, enhance drug development, and drive the next wave of precision medicine....
Breakthrough bioactive glass device offers surgeons a safe, resorbable, and cost-effective alternative to metal implants, engineered to accelerate bone regeneration and streamline surgical workflow....
Alliance integrates Siemens’ digital pathology solutions with Evident’s Pramana platform to modernize diagnostics, unify clinical workflows, and advance AI-driven personalised healthcare in Germany....
One-Time Income Release and Improved Gross Margins Strengthen Financials...
The RAD Temp ensures uninterrupted cancer treatment in Northeast Texas as TRMC upgrades its vault and linear accelerator for more precise, advanced care....
Phase 3 AURA 1 trial meets primary endpoint paving way for new treatment option in China...
Quarterly intensive program now offers transformative rehab for more neurological conditions ...
New feature enables compatibility with almost any fluoroscopic C-arm, advancing global lung cancer diagnostics...
